ImpediMed Ltd
ASX:IPD
ImpediMed Ltd
ASX:IPD
Price:
0.07 AUD
-1.41%
Market Closed
Updated:
Jun 8, 2024
ImpediMed Ltd
EPS (Diluted)
|
ImpediMed Ltd
EPS (Diluted) Peer Comparison
Comparables:
NTI
C
CYC
COH
OIL
EMV
Competitive EPS (Diluted) Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | EPS (Diluted) | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
ImpediMed Ltd
ASX:IPD
|
EPS (Diluted)
AU$0
|
CAGR 3-Years
21%
|
CAGR 5-Years
30%
|
CAGR 10-Years
13%
|
|
|
Neurotech International Ltd
ASX:NTI
|
EPS (Diluted)
AU$0
|
CAGR 3-Years
0%
|
CAGR 5-Years
20%
|
CAGR 10-Years
N/A
|
|
C
|
Cyclopharm Ltd
ASX:CYC
|
EPS (Diluted)
AU$0
|
CAGR 3-Years
15%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
12%
|
|
|
Cochlear Ltd
ASX:COH
|
EPS (Diluted)
AU$5
|
CAGR 3-Years
N/A
|
CAGR 5-Years
3%
|
CAGR 10-Years
15%
|
|
|
Optiscan Imaging Ltd
ASX:OIL
|
EPS (Diluted)
AU$0
|
CAGR 3-Years
N/A
|
CAGR 5-Years
0%
|
CAGR 10-Years
0%
|
|
|
EMvision Medical Devices Ltd
ASX:EMV
|
EPS (Diluted)
AU$0
|
CAGR 3-Years
6%
|
CAGR 5-Years
-38%
|
CAGR 10-Years
N/A
|
See Also
What is ImpediMed Ltd's EPS (Diluted)?
EPS (Diluted)
-0
AUD
-0
AUD
Based on the financial report for Dec 31, 2023, ImpediMed Ltd's EPS (Diluted) amounts to -0 AUD.
What is ImpediMed Ltd's EPS (Diluted) growth rate?
EPS (Diluted) CAGR 10Y
13%
13%
Over the last year, the EPS (Diluted) growth was 0%. The average annual EPS (Diluted) growth rates for ImpediMed Ltd have been 21% over the past three years , 30% over the past five years , and 13% over the past ten years .
You don't have any saved screeners yet
